Profitability Metrics

Gross Margin
12.49%
Operating Margin
3.34%
Net Margin
10.82%

Efficiency Metrics

Revenue per Expense Ratio
1.03
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
16.57%
Income Tax Rate
24.32%
EPS
4.7200000000

Balance Sheet Analysis

Current Ratio
1.86
Cash Ratio
0.01
Working Capital
$373.10M
Debt to Equity
0.75
Debt to Assets
28.22%
Equity Ratio
37.49%

Cash Flow Analysis

Operating Cash Flow Ratio
2.21%
Free Cash Flow Ratio
1.21%
CapEx to Revenue
1.00%
Dividends Paid
$12.50M
Stock Buybacks
$8.30M
Total Shareholder Returns
$20.80M
Cash Position Change
-72.27%

Key Takeaways (2024 FY)

  • Revenue declined by 9.7725549658832%, indicating potential market challenges
  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 1,604.98%

Detailed Growth Metrics

Core Performance

Revenue
-9.77%
Net Income
468.65%
EPS
512.99%
Operating Income
-10.16%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-11.62%
Operating Cash Flow
-57.79%
Free Cash Flow
-72.47%

Balance Sheet Health

Assets
-14.00%
Debt
-37.03%
Book Value per Share
-6.12%
Inventory
-8.35%

Shareholder Returns

Dividends per Share
1,604.98%
Shares Outstanding
-6.93%

Long Term Trends

3Y Revenue/Share
16.12%
5Y Revenue/Share
13.92%
3Y Dividend/Share
3,278.82%
5Y Dividend/Share
1,667.14%